Quarterly report pursuant to Section 13 or 15(d)

DISCONTINUED OPERATIONS (Tables)

v3.23.3
DISCONTINUED OPERATIONS (Tables)
 9 Months Ended
Sep. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
SCHEDULE OF COMPONENTS OF ASSETS AND LIABILITIES AND REVENUE CLASSIFIED AS DISCONTINUED OPERATIONS

The table below presents the significant components of its former Pharma Solutions business unit’s results included within loss from discontinued operations, net of tax in the condensed consolidated statements of operations for the three- and nine months ended September 30, 2023 and 2022.

 

    2023     2022     2023     2022  
    For The Three Months Ended     For The Nine Months Ended  
    September 30,     September 30,  
    2023     2022     2023     2022  
             
Revenue, net   $ -     $ 1,267     $ -     $ 5,678  
                                 
Loss from discontinued operations     -       (13,012 )     (137 )     (15,888 )
Income tax expense     86       (58 )     248       48  
Loss from discontinued operations, net of tax   $ (86 )   $ (12,954 )   $ (385 )   $ (15,936 )